Single-Cell Omics

Global Single-Cell Omics Market to Reach US$4.3 Billion by 2030

The global market for Single-Cell Omics estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Single-Cell Genomics, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Single-Cell Transcriptomics segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$498.8 Million While China is Forecast to Grow at 20.9% CAGR

The Single-Cell Omics market in the U.S. is estimated at US$498.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$958.8 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.2% and 14.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Single-Cell Omics Market – Key Trends & Drivers Summarized

How Is Single-Cell Omics Transforming Biomedical Research? Exploring Its Role in Precision Medicine and Disease Understanding

The field of single-cell omics has revolutionized biomedical research by enabling scientists to analyze the molecular and genetic characteristics of individual cells, rather than averaging signals from bulk cell populations. This approach provides unprecedented insights into cellular heterogeneity, allowing researchers to study rare cell populations, track disease progression, and uncover new therapeutic targets. Single-cell omics encompasses multiple disciplines, including single-cell genomics, transcriptomics, proteomics, and metabolomics, all of which contribute to a more comprehensive understanding of cellular functions. These techniques have proven particularly valuable in oncology, immunology, neuroscience, and regenerative medicine, where cellular diversity plays a critical role in disease mechanisms. By enabling high-resolution profiling of cells, single-cell omics is helping researchers develop more targeted therapies, paving the way for precision medicine. As scientific interest in personalized healthcare grows, the demand for advanced single-cell analysis tools continues to expand, fueling market growth.

What Technological Advancements Are Enhancing Single-Cell Omics? Examining Innovations in Data Analysis and Instrumentation

Recent advancements in sequencing technologies, microfluidics, and bioinformatics have significantly improved the efficiency and scalability of single-cell omics studies. Next-generation sequencing (NGS) platforms, combined with droplet-based and microfluidic cell isolation techniques, have enabled high-throughput single-cell analysis, making it possible to process thousands of cells simultaneously. Artificial intelligence (AI) and machine learning (ML) have also played a critical role in enhancing data interpretation, allowing researchers to extract meaningful biological insights from vast and complex datasets. Additionally, the integration of multi-omics approaches, where genomics, proteomics, and metabolomics data are analyzed together, has provided a more holistic view of cellular behavior. These innovations have improved the reproducibility, sensitivity, and cost-effectiveness of single-cell omics technologies, making them more accessible for both academic and clinical research settings. As technology continues to evolve, single-cell analysis tools are expected to become even more sophisticated, expanding their applications in drug discovery and disease modeling.

What Challenges Are Hindering the Adoption of Single-Cell Omics? Addressing Cost, Complexity, and Data Interpretation Issues

Despite its transformative potential, the widespread adoption of single-cell omics faces several challenges, including high costs, technical complexity, and data analysis limitations. The instrumentation and reagents required for single-cell sequencing and multi-omics profiling remain expensive, limiting their accessibility in resource-constrained research environments. Additionally, the technical expertise needed to isolate and process single cells without introducing bias or artifacts poses a challenge for many laboratories. The massive volume of data generated by single-cell omics studies also presents computational challenges, requiring advanced bioinformatics tools and cloud-based platforms for efficient storage and analysis. Standardization across experimental protocols and data interpretation remains a key issue, as variability in techniques can lead to inconsistent results across different studies. Addressing these challenges requires continued investment in cost-effective technologies, improved computational tools, and standardized workflows to ensure the reliability and reproducibility of single-cell omics research.

What’s Driving the Growth of the Single-Cell Omics Market? Identifying Key Expansion Factors and Industry Trends

The growth in the single-cell omics market is driven by several factors, including increasing funding for precision medicine research, advancements in sequencing technology, and the rising prevalence of complex diseases such as cancer and neurodegenerative disorders. Governments and private organizations are heavily investing in single-cell analysis tools to accelerate biomedical discoveries and drug development. Additionally, the growing need for early disease detection and biomarker discovery has boosted the adoption of single-cell omics in clinical research and diagnostics. The integration of AI and cloud computing in single-cell data analysis has further streamlined workflows, making these technologies more accessible for a broader range of applications. Moreover, pharmaceutical companies are leveraging single-cell omics for targeted drug development and personalized treatment strategies, expanding the commercial potential of the market. With continued technological advancements and increasing demand for precision healthcare, the single-cell omics market is poised for substantial growth, revolutionizing how diseases are studied and treated at the cellular level.

SCOPE OF STUDY:

The report analyzes the Single-Cell Omics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics); Application (Oncology, Cell Biology, Neurology, Immunology); End-Use (Pharma & Biotech Companies, Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• 10x Genomics
• Agilent Technologies Inc.
• ANGLE plc
• Becton, Dickinson and Company (BD)
• BGI Genomics Co. Ltd
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Celldom, Inc.
• CELLENION
• CYTENA GmbH
• Danaher Corporation
• Dolomite Bio
• Epicypher Inc.
• Fluidigm Corporation
• Fluxion Biosciences
• Illumina, Inc.
• Miltenyi Biotec B.V. & Co. KG
• Mission Bio, Inc.
• NanoString Technologies, Inc.
• Pacific Biosciences
• PerkinElmer Inc.
• Proteona
• QIAGEN N.V.
• Scipio Bioscience
• Single Cell Discoveries
• Singleron Biotechnologies
• Singulomics
• Standard BioTools Inc.
• Takara Bio Group
• Thermo Fisher Scientific

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.